Overall, investment in Swiss biotech companies almost tripled on the previous year’s figure. It amounted to 3.44 billion Swiss francs. Investment in research and development…
Julijana06.05.2021
We have several projects and companies that are further building out their teams. A particular focus is on people with scientific (immunology, oncology, neuroscience, gene & cell therapy, biologics) leadership track record in the…
Julijana18.03.2021
The term "bifunctional molecules" covers a collection of related modalities with different but similar strategies. They are opening up once-inaccessible targets and enabling the development…
Julijana18.03.2021
Under the current tax framework, the non-uniform cantonal tax practices on the capital gains treatment and valuation of employee shares lead to different tax consequences…
Julijana18.03.2021
Nowadays, biotech headlines usually talk about hundred million series A financings, oversubscribed IPOs, or multi-billion exits. But success is not guaranteed at all, even when…
Mariela Salas18.03.2021
In this paper, "Driving value from genomics in life sciences: rising to the data challenge", KPMG explores the cornerstone for genomic data leadership: a robust…
Mariela Salas18.03.2021
“We are very excited to announce this partnership with Walder Wyss. They have advised several of our companies during their financing rounds and we have…
Julijana01.03.2021
Looking back at 2020: We only turned 4 this year, and have had a great journey so far, but we still have so much more to…
Mariela Salas16.12.2020
European health systems are under pressure because of the aging population, the increasing amount of chronic diseases and a rise of healthcare costs caused by…
Mariela Salas08.12.2020
